At OncoNano Medicine, we are committed to developing products that bring new, innovative therapies to patients with serious or life-threatening illnesses or conditions. As we are focused on our clinical studies, we do not currently offer access to our investigational product(s) outside of these studies. If you or someone you know would like to learn more about OncoNano Medicine’s clinical trials, we encourage you to view our trials at www.clinicaltrials.gov.  

At this time, OncoNano does not offer an Expanded Access Program (sometimes referred to as “compassionate use” or “pre-approval access”) and we are not accepting expanded access requests. As we continue to develop investigational product(s), we will review our expanded access policy and may make updates.  

If you have additional questions regarding this policy, please speak with your health care provider or contact us at info@onconanomed.com.